Effects of Progesterone and its Metabolites on Human Granulosa Cells

Abstract

The corpus luteum (CL) is under control of gonadotrophic hormones and produces progesterone, which is necessary for endometrial receptivity. Recent studies have shown that progesterone and its metabolites are involved in cell proliferation and apoptosis of cancer cells. Here weanalyzed the role of progesterone and its meta­bolites on luteinized granulosa cells (LGC) by FACS analysis and quantitative Real-Time PCR. We detected the mRNA of the progesterone metabolizing genes SRD5A1, AKR1C1, and AKR1C2 in LGC. The stimulation of LGC with progesterone or progesterone metabolites did not show any effect on the mRNA expression of these genes. However, a downregulation of Fas expression was found to be accomplished by progesterone and human chorionic gonadotropin. Our findings do not support the concept of an effect of progesterone metabolites on LGCs. However, it suggests an antiapoptotic effect of hCG and progesterone during corpus luteum development by downregulation of Fas.

Key words

chorionic gonadotropin - apoptosis - in vitro fertilization - corpus luteum

• References

• 1 Zheng J, Fricke PM, Reynolds LP, Redmer DA. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Biol Reprod 1994; 9: 1589-1595
• 2 Quirk SM, Cowan RG, Harman RM. Progesterone receptor and the cell cycle modulate apoptosis in granulosa cells. Endocrinology 2004; 145: 5033-5043
• 3 Giguere V, Yang N, Segui P, Evans RM, Yang X, Lamia KA. Identification of a new class of steroid hormone receptors. Nature 1988; 331: 91-94
• 4 Peluso JJ, Romak J, Liu X. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone’s antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology 2008; 149: 534-543
• 5 Duncan WC, Hillier SG, Gay E, Bell J, Fraser HM. Non-genomic action of estradiol and progesterone on cytosolic calcium concentrations in primary cultures of human granulosa-lutein cells. J Clin Endocrinol Metab 2005; 20: 2383-2390
• 6 Lydon JP, DeMayo FJ, Conneely OM, O’Malley BW. Reproductive phenotpes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 1996; 56 (1–6 Spec No) 67-77
• 7 Svensson EC, Markstrom E, Shao R, Andersson M, Billig H. Progesterone receptor antagonists Org 31710 and RU 486 increase apoptosis in human periovulatory granulosa cells. Fertil Steril 2001; 76: 1225-1231
• 8 Makrigiannakis A, Coukos G, Christofidou-Solomidou M, Montas S, Coutifaris C. Progesterone is an autocrine/paracrine regulator of human granulosa cell survival in vitro. Ann N Y Acad Sci 2000; 900: 16-25
• 9 Engmann L, Losel R, Wehling M, Peluso JJ. Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism. J Clin Endocrinol Metab 2006; 91: 4962-4968
• 10 Thomas P. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol 2008; 29: 292-312
• 11 Wiebe JP, Muzia D, Hu J, Szwajcer D, Hill SA, Seachrist JL. The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion. Cancer Res 2000; 60: 936-943
• 12 Hill M, Parizek A, Kancheva R, Jirasek JE. Reduced progesterone meta­bolites in human late pregnancy. Physiol Res 2011; 60: 225-241
• 13 Wiebe JP, Lewis MJ, Cialacu V, Pawlak KJ, Zhang G. The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics. J Steroid Biochem Mol Biol 2005; 93: 201-208
• 14 Wiebe JP, Beausoleil M, Zhang G, Cialacu V. Opposing actions of the progesterone metabolites, 5alpha-dihydroprogesterone (5alphaP) and 3alpha-dihydroprogesterone (3alphaHP) on mitosis, apoptosis, and expression of Bcl-2, Bax and p21 in human breast cell lines. J Steroid Biochem Mol Biol 2010; 118: 125-132
• 15 Lewis MJ, Wiebe JP, Heathcote JG. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 2004; 4: 27
• 16 Hevir N, Vouk K, Sinkovec J, Ribic-Pucelj M, Rizner TL. Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis. Chem Biol Interact 2011; 191: 217-226
• 17 Tetsuka M, Yamamoto S, Hayashida N, Hayashi KG, Hayashi M, Acosta TJ, Miyamoto A, Vaskivuo TE, Tapanainen JS. Apoptosis in the human ovary. J Endocrinol 2003; 6: 24-35
• 18 Yoshida S, Ohara N, Xu Q, Chen W, Wang J, Nakabayashi K, Sasaki H, Morikawa A, Maruo T. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med 2010; 28: 260-273
• 19 Herr D, Keck C, Tempfer C, Pietrowski D. Chorionic gonadotropin regulates the transcript level of VHL, p53, and HIF-2alpha in human granulosa lutein cells. J Clin Endocrinol Metab 2004; 69: 397-401
• 20 Chen X, Gao H, Wei P, Zhang Z, Liu Y. Expression of apoptosis-related genes Fas/FasL, Bax/Bcl-2 and Caspase-3 in rat corpus luteum during luteal regression. Sci China C Life Sci 2003; 46: 273-285
• 21 Matsuda-Minehata F, Inoue N, Goto Y, Manabe N. The regulation of ovarian granulosa cell death by pro- and anti-apoptotic molecules. J Reprod Dev 2006; 52: 695-705
• 22 Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1: 1458-1461
• 23 Stouffer RL. Progesterone as a mediator of gonadotrophin action in the corpus luteum: beyond steroidogenesis. Hum Reprod Update 2003; 9: 99-117
• 24 Shao R, Markstrom E, Friberg PA, Johansson M, Billig H. Expression of progesterone receptor (PR) A and B isoforms in mouse granulosa cells: stage-dependent PR-mediated regulation of apoptosis and cell proliferation. Biol Reprod 2003; 68: 914-921
• 25 Peluso JJ. Multiplicity of progesterone’s actions and receptors in the mammalian ovary. Biol Reprod 2006; 75: 2-8
• 26 Kuranaga E, Kanuka H, Bannai M, Suzuki M, Nishihara M, Takahashi M. Fas/Fas ligand system in prolactin-induced apoptosis in rat corpus luteum: possible role of luteal immune cells. Biochem Biophys Res Commun 1999; 260: 167-173
• 27 Matsubara H, Ikuta K, Ozaki Y, Suzuki Y, Suzuki N, Sato T, Suzumori K. Gonadotropins and cytokines affect luteal function through control of apoptosis in human luteinized granulosa cells. J Clin Endocrinol Metab 2000; 85: 1620-1626
• 28 Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 2010; 8: 102
• 29 VandeVoort CA, Overstreet JW, Lasley BL, Stewart DR. Effects of progesterone receptor blockers on human granulosa-luteal cell culture secretion of progesterone, estradiol, and relaxin. Biol Reprod 2000; 62: 200-205
• 30 Lai KW, Cheng LY, Cheung AL O WS Inhibitor of apoptosis proteins and ovarian dysfunction in galactosemic rats. Cell Tissue Res 2003 311. 417-425
• 31 Kuranaga E, Kanuka H, Hirabayashi K, Suzuki M, Nishihara M, Takahashi M. Progesterone is a cell death suppressor that downregulates Fas expression in rat corpus luteum. FEBS Lett 2000; 466: 279-282
• 32 Meyer HH, Jewgenow K, Hodges JK. Binding activity of 5alpha-reduced gestagens to the progestin receptor from African elephant (Loxodonta africana). Gen Comp Endocrinol 1997; 105: 164-167